Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Oncology Center of Excellence

Oncology Center of Excellence

                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          Immuno-OncologyOncology Center of Excellence Immuno-Oncology
  
  	
    Share
    Post
    Linkedin

    Email
    PrintImmuno-oncology therapeutics is leading to a transformational shift in treatment paradigms for patients with cancer. Development of novel drugs, biologics, and devices will likely lead to more effective therapies tailored to the unique immune biology within each cancer patient to stimulate, and orchestrate the body’s natural defenses as a treatment for their cancer while minimizing toxicities.
The Immuno-Oncology Therapeutics Program (IOTP) in the FDA Oncology Center of Excellence (OCE) will bring together existing expertise across the Centers within FDA and serve to promote development of new therapeutics that focus on harnessing the immune system to engage new, more efficacious treatment paradigms for patients with cancer. The IOTP will foster:

**Internal and External Education Programs**

	Education programs within the FDA to serve the training needs of staff to develop and to maintain expertise in the rapidly evolving field of immuno-oncology.
		Communication programs with stakeholders of immuno-oncology therapeutics, including already approved products and novel products in development, to engage this community on the role of the OCE in furthering the development of immuno-oncology therapeutics.
	**Regulatory Science Research** to advance the development of immuno-oncology drugs, biologics, and devices in a manner that is guided by the unique features of these therapies that work directly with the biology of the immune system to deliver an effective cancer treatment.
	**Novel Clinical Trial Paradigm** advancement to efficiently evaluate the safety and effectiveness of immuno-oncology therapeutics, including combination regimens, as unique treatments that promise broad activity across cancer types.

                                                                                  Content current as of:
      02/01/2018Oncology Center of Excellence

          
                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop